每年出版 4 期
ISSN 打印: 0893-9675
ISSN 在线: 2162-6448
Indexed in
Iron in Multiple Myeloma
摘要
Multiple myeloma is a non-curable B-cell malignancy in which iron metabolism plays an important role. Patients with this disorder almost universally suffer from clinically significant anemia, which is often symptomatic, and which is due to impaired iron utilization. Recent studies have indicated that the proximal cause of dysregulated iron metabolism and anemia in these patients is cytokine-induced upregulation of hepcidin expression. Malignant myeloma cells are dependent on an increased influx of iron, and therapeutic efforts are being made to target this requirement. The studies detailing the characteristics and biochemical abnormalities in iron metabolism causing anemia and the initial attempts to target iron therapeutically are described in this review.
-
Wang Jing, Xie Xin, Cheng Feng, Zhou Xin, Xia Jun, Qian Xifeng, Wang Lingling, Guo Hongfeng, Evaluation of pretreatment red cell distribution width in patients with multiple myeloma, Cancer Biomarkers, 20, 3, 2017. Crossref
-
Leoh Lai Sum, Kim Yoon Kyung, Candelaria Pierre V., Martínez-Maza Otoniel, Daniels-Wells Tracy R., Penichet Manuel L., Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma, The Journal of Immunology, 200, 10, 2018. Crossref
-
Banaszkiewicz , Małyszko , Vesole , Woziwodzka , Jurczyszyn , Żórawski , Krzanowski , Małyszko , Batko , Kuźniewski , Krzanowska , New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia, Journal of Clinical Medicine, 8, 11, 2019. Crossref
-
Suvannasankha Attaya, Tompkins Douglas R., Edwards Daniel F., Petyaykina Katarina V., Crean Colin D., Fournier Pierrick G., Parker Jamie M., Sandusky George E., Ichikawa Shoji, Imel Erik A., Chirgwin John M., FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells, Oncotarget, 6, 23, 2015. Crossref
-
Camiolo Giuseppina, Barbato Alessandro, Giallongo Cesarina, Vicario Nunzio, Romano Alessandra, Parrinello Nunziatina L., Parenti Rosalba, Sandoval Joaquín Cantón, García-Moreno Diana, Lazzarino Giacomo, Avola Roberto, Palumbo Giuseppe A., Mulero Victoriano, Li Volti Giovanni, Tibullo Daniele, Di Raimondo Francesco, Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib, Redox Biology, 36, 2020. Crossref
-
Candelaria Pierre V., Leoh Lai Sum, Penichet Manuel L., Daniels-Wells Tracy R., Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents, Frontiers in Immunology, 12, 2021. Crossref
-
Banaszkiewicz Małgorzata, Małyszko Jolanta, Batko Krzysztof, Koc-Żórawska Ewa, Żórawski Marcin, Dumnicka Paulina, Jurczyszyn Artur, Woziwodzka Karolina, Maleszka Aleksandra, Krzanowski Marcin, Kraśniak Andrzej, Drożdż Ryszard, Krzanowska Katarzyna, The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment, Medicina, 58, 3, 2022. Crossref
-
Xiang-tao Pan, Expression of Hepcidin and Neogenin in colorectal cancer, Open Medicine, 12, 1, 2017. Crossref
-
Gu Zhimin, Wang He, Xia Jiliang, Yang Ye, Jin Zhendong, Xu Hongwei, Shi Jumei, De Domenico Ivana, Tricot Guido, Zhan Fenghuang, Decreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation, Cancer Research, 75, 11, 2015. Crossref
-
Livandovskii U. A, Rybina O. B, Multiple myeloma with monoclonal immunoglobulin A exhibiting and hypercholesterolemia: case report and literature review, CardioSomatics, 6, 1, 2015. Crossref